All sites C00-96,D32-33,D42-43,D45-47,D76 727 89.5 1.7 5.6 0.7 2.4
Mouth, pharynx C00-14 19 96.8 2.2 - - 1.1
  Lip C00 4 100.0 - - - -
  Tongue C02 4 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 1 80.0 20.0 - - -
  Pharynx C01,C09-14 7 94.1 2.9 - - 2.9
Digestive organs C15-26 153 85.1 0.3 11.0 1.4 2.2
  Oesophagus C15 10 97.9 - 2.1 - -
  Stomach C16 17 95.3 - 2.4 - 2.4
  Small intestine C17 3 93.8 - - - 6.3
  Colon C18 42 97.6 - 0.9 - 1.4
  Rectum, rectosigmoid C19-20 26 94.7 - 2.3 3.1 -
  Anus C21 1 66.7 - - 33.3 -
  Liver C22 18 70.0 - 23.3 2.2 4.4
  Gallbladder, bile ducts C23-24 5 73.1 - 26.9 - -
  Pancreas C25 28 60.4 1.4 33.8 0.7 3.6
  Other digestive organs C26 3 64.7 - 5.9 17.6 11.8
Respiratory organs C30-39 95 73.1 8.2 12.6 1.3 4.8
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 5 100.0 - - - -
  Lung, trachea C33-34 89 71.7 8.8 13.3 1.3 4.9
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 2 100.0 - - - -
Melanoma of the skin C43 30 100.0 - - - -
Skin, non-melanoma C44 43 100.0 - - - -
Mesothelioma C45 3 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 6 100.0 - - - -
Breast C50 1 100.0 - - - -
Male genital organs C60-63 208 99.2 - 0.2 0.1 0.5
  Prostate C61 202 99.2 - 0.2 0.1 0.5
  Testis C62 4 100.0 - - - -
  Other male genital C60,C63 2 100.0 - - - -
Urinary organs C64-68 66 93.6 0.3 4.8 0.6 0.6
  Kidney C64 24 87.4 - 11.8 0.8 -
  Bladder and urinary tract2 C65-68 42 97.2 0.5 0.9 0.5 0.9
Eye C69 0 50.0 - - 50.0 -
Brain, central nervous system C70-72,D32-33,D42-43 20 82.0 - 13.0 1.0 4.0
Thyroid gland C73 5 95.8 - - - 4.2
Other endocrine glands C74-75 1 66.7 - 33.3 - -
Illdefined or unknown C76,C80 12 69.0 3.4 20.7 1.7 5.2
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 64 79.0 5.0 4.7 1.3 10.0
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 32 100.0 - - - -
  Malignant immunoproliferative diseases C88 1 33.3 - 66.7 - -
  Myeloma and other plasma cell tumors C90 8 44.7 - 34.2 7.9 13.2
  Leukaemia C91-95 12 61.7 21.7 - 1.7 15.0
  Myelodysplastic syndromes D46 4 33.3 14.3 - - 52.4
  Myeloproliferaitive neoplasms D45,D47 4 63.2 - - - 36.8
Not included above
  Basal cell carcinoma of the skin 289 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.